PT97062A - Metodo para a utilizacao de tenidap como inibidor da libertacao de elastase por neutrofilos - Google Patents

Metodo para a utilizacao de tenidap como inibidor da libertacao de elastase por neutrofilos

Info

Publication number
PT97062A
PT97062A PT97062A PT9706291A PT97062A PT 97062 A PT97062 A PT 97062A PT 97062 A PT97062 A PT 97062A PT 9706291 A PT9706291 A PT 9706291A PT 97062 A PT97062 A PT 97062A
Authority
PT
Portugal
Prior art keywords
tenidap
elastase
neutrophilos
libertacation
inhibitor
Prior art date
Application number
PT97062A
Other languages
English (en)
Other versions
PT97062B (pt
Inventor
Leland David Loose
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT97062A publication Critical patent/PT97062A/pt
Publication of PT97062B publication Critical patent/PT97062B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97062A 1990-03-19 1991-03-18 Metodo para a utilizacao de tenidap como inibidor da libertacao de elastase por neutrofilos PT97062B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/495,888 US5006547A (en) 1990-03-19 1990-03-19 Tenidap as an inhibitor of the release of elastase by neutrophils

Publications (2)

Publication Number Publication Date
PT97062A true PT97062A (pt) 1991-10-31
PT97062B PT97062B (pt) 1998-07-31

Family

ID=23970396

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97062A PT97062B (pt) 1990-03-19 1991-03-18 Metodo para a utilizacao de tenidap como inibidor da libertacao de elastase por neutrofilos

Country Status (17)

Country Link
US (1) US5006547A (pt)
EP (1) EP0448261B1 (pt)
JP (1) JPH0678230B2 (pt)
KR (1) KR960016511B1 (pt)
AT (1) ATE133071T1 (pt)
AU (1) AU629109B2 (pt)
CA (1) CA2038410C (pt)
DE (1) DE69116404T2 (pt)
DK (1) DK0448261T3 (pt)
HU (1) HU212492B (pt)
IE (1) IE70732B1 (pt)
IL (1) IL97520A (pt)
MY (1) MY107227A (pt)
NZ (1) NZ237450A (pt)
PH (1) PH27229A (pt)
PT (1) PT97062B (pt)
ZA (1) ZA911980B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
US5545656A (en) * 1995-04-05 1996-08-13 Pfizer Inc. 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
EP1390062A4 (en) * 2001-05-02 2005-09-14 Blood Res Center MODULATORS OF ELASTASE INHIBITOR SECRETION
WO2007103540A2 (en) 2006-03-08 2007-09-13 Pharmena North America Inc. Combination therapy with non-selective cox inhibitors to prevent cox-related gastric injuries
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4678802A (en) * 1985-07-09 1987-07-07 Pfizer Inc. 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
EP0287196B1 (en) * 1987-02-18 1994-11-23 Beecham Group Plc Indole derivatives, process for their preparation and pharmaceutical compositions containing them
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
DE69116404D1 (de) 1996-02-29
HUT60622A (en) 1992-10-28
EP0448261A3 (en) 1992-04-08
NZ237450A (en) 1997-02-24
ZA911980B (en) 1992-10-28
EP0448261A2 (en) 1991-09-25
PH27229A (en) 1993-05-04
KR910016327A (ko) 1991-11-05
EP0448261B1 (en) 1996-01-17
DK0448261T3 (da) 1996-02-12
IE70732B1 (en) 1996-12-11
HU212492B (en) 1996-07-29
IL97520A0 (en) 1992-06-21
KR960016511B1 (ko) 1996-12-14
DE69116404T2 (de) 1996-05-30
AU7358691A (en) 1992-08-06
ATE133071T1 (de) 1996-02-15
MY107227A (en) 1995-10-31
JPH0678230B2 (ja) 1994-10-05
JPH04234814A (ja) 1992-08-24
HU910871D0 (en) 1991-09-30
PT97062B (pt) 1998-07-31
IL97520A (en) 1995-12-31
CA2038410C (en) 1995-01-24
IE910861A1 (en) 1991-09-25
AU629109B2 (en) 1992-09-24
US5006547A (en) 1991-04-09

Similar Documents

Publication Publication Date Title
ATE401092T1 (de) Gereinigte zusammensetzungen von newcastle- krankheitvirus
BR9708360A (pt) Divisor de feixe não-polarizante e processo para produzir o mesmo
ATE225341T1 (de) In 6-position durch thio substituierte paclitaxele
PT627221E (pt) Substancias antagonistas p para o tratamento de emese
FI901085A0 (fi) Biosidisia koostumuksia ja menetelmiä, joissa niitä käytetään
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
BR9100046A (pt) Derivados de azaoxindole,composicao farmaceutica e processo para o tratamento de mamiferos
PT97062A (pt) Metodo para a utilizacao de tenidap como inibidor da libertacao de elastase por neutrofilos
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
DE69123363D1 (de) Neue zusammensetzungen
DK0513409T3 (da) Anvendelse af et mikrobicidt middel ved fremstilling af betontagsten
CO5221050A1 (es) Composicion limpiadora que comprende un depurados de radicales, para limpieza eficaz y estabilidad mejorada en almacenamiento
BR9102635A (pt) Derivado de pirazolcarboxamida,composicao fungicida e acaricida e processo para produzir derivado de pirazolcarboxamida
BR9913936A (pt) Processo para prevenir ou tratar periodontite em um mamìfero, e, uso de uma composição antimicrobiana
BR9813357A (pt) Composição de barra, e, processo para fornecer atividade bacteriostática
MX9205257A (es) Dihidropiridinas substituidas por indolsulfonamida y procedimiento para su fabricacion.
DK0471040T3 (da) Anvendelse af cromakalim/BRL 38227 til behandling af hyperreaktivitet i luftveje
IT1320914B1 (it) Unita' per la lavorazione di pannelli di legno o similari.
ES1023936Y (es) Cajon para marcar ganado.
SE9202434D0 (sv) Skatolinaktiverande komposition
ES521091A0 (es) Mejoras en el objeto de la patente principal no 513.956 por procedimiento para la carbonilacion de olefinas y esteres organicos.
ES1014974Y (es) Punta de anclaje para varillas en taladros practicados en tableros o piezas de madera.
ES512654A0 (es) "mejoras introducidas en el objeto de la patente principal n 497.716, por: perfeccionamientos introducidos en las correderas sencillas o de giro para lama verticales".
ES1014799Y (es) Maquina recreativa de competicion pura o deporte para el juego de la rana.
ES2025787T3 (es) Procedimiento de tratamiento de madera.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910710

FG3A Patent granted, date of granting

Effective date: 19980417

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19991031